Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis
Titel:
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis
Auteur:
Gao, Jennifer J Cheng, Joyce Prowell, Tatiana M Bloomquist, Erik Tang, Shenghui Wedam, Suparna B Royce, Melanie Krol, Danielle Osgood, Christy Ison, Gwynn Sridhara, Rajeshwari Pazdur, Richard Beaver, Julia A Amiri-Kordestani, Laleh